Search - tctmd.com

Displaying 321 - 337 of 337

Sort: Relevancy | Date

News Daily News

Expert Consensus Highlights Needs of Cancer Patients in the Cath Lab and Beyond

L.A. McKeown

January 12, 2016

News Conference News TCT 2015

Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care

Yael L. Maxwell

October 12, 2015

News Daily News

Female Interventionalists Remain a Rarity in the United States

Yael L. Maxwell

August 21, 2015

News Daily News

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Todd Neale

July 16, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

CoreValve在高风险患者中的生存益处到2年时依然持续存在

July 07, 2015

News Daily News

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

L.A. McKeown

July 01, 2015

News Industry News

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

June 24, 2015

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Daily News

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

July 25, 2013

News Daily News

European TAVR Usage Tied to Economics, Reimbursement

Yael L. Maxwell

July 12, 2013

Presentation TCT 2012

Hemodynamics and Interactive Calculations for Aortic Stenosis Using the "John Madden" Telestrator

Presenter: Tim Lapp

October 22, 2012

News Daily News

Late-Night Calls Do Not Adversely Affect Operators’ Next-Day PCI

Leah Lawrence

April 10, 2012

News Daily News

FDA, CMS Parallel Review Aims to Speed Access to Innovative Technologies

L.A. McKeown

October 14, 2011

News Conference News

PARTNER: TAVI Cost Effective Compared With Standard Care

Jason Kahn

April 03, 2011

Advertisement

Expert Consensus Highlights Needs of Cancer Patients in the Cath Lab and Beyond

Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care

Female Interventionalists Remain a Rarity in the United States

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

CoreValve在高风险患者中的生存益处到2年时依然持续存在

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

Innovation in Intervention: Perspectives from Industry

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

European TAVR Usage Tied to Economics, Reimbursement

Hemodynamics and Interactive Calculations for Aortic Stenosis Using the "John Madden" Telestrator

Late-Night Calls Do Not Adversely Affect Operators’ Next-Day PCI

FDA, CMS Parallel Review Aims to Speed Access to Innovative Technologies

PARTNER: TAVI Cost Effective Compared With Standard Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content